UroGen Pharma: An Emerging GARP Stock

UroGen Pharma (URGN) is an emerging growth at a reasonable price (GARP) stock, according to a Wall Street analyst. The analyst believes that URGN's strong fundamentals make it an attractive investment opportunity.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.

Join Navvyx - it's Free